COVID-19: vaccine and drug development updates
Providing the latest news in the understanding of SARS-CoV-2, drug development and clinical trials for a COVID-19 vaccine with regular updates. If you would like to keep up to date with our content on coronavirus, you can sign up for our site here, where you can subscribe to our newsletters for free! Drug discovery and development 07 December 2020 Mass spectrometry has helped reveal how infection with SARS-CoV-2 changes levels of host proteins and pathways in lung cells, bringing to light potential new drug targets. MK-4482/EIDD-2801 (or more pleasingly, Molnupiravir) is in Phase II/III trials. Recently published results using a ferret model...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
